Since RNA based analyses of normal tissues suggest that CELA3B expression is completely limited to the pancreas, CELA3B antibodies may assist in the distinction of pancreatic from extrapancreatic cancers and perhaps also in the distinction of acinar cell carcinoma from ductal adenocarcinoma of the pancreas. Here, CELA3B is linked to pancreatic ductal adenocarcinoma.